SCHEDULE 13G/A: Morgan Stanley Amends Axogen, Inc. Stake Disclosure, Subsidiary Drops Below 5% Threshold
Beneficial Ownership Amendment
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amended Schedule 13G for Axogen, Inc., disclosing a 5.3% beneficial ownership by Morgan Stanley, while Morgan Stanley Capital Services LLC has ceased to be a beneficial owner of more than five percent of the common stock.
Summary
- Morgan Stanley reported beneficial ownership of 2,330,406 shares of Axogen, Inc. common stock, representing 5.3% of the class, as of December 31, 2024.
- Morgan Stanley Capital Services LLC, a wholly-owned subsidiary of Morgan Stanley, reported beneficial ownership of 1,605,019 shares, representing 3.6% of the class, as of December 31, 2024.
- Morgan Stanley Capital Services LLC has ceased to be a beneficial owner of more than five percent of Axogen, Inc. common stock as of the filing date.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously filed statement.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to Morgan Stanley Capital Services LLC ceasing to be a beneficial owner of more than 5%, which implies a reduction in their stake below a key reporting threshold. While not a direct negative performance indicator, it can be interpreted as a decrease in institutional conviction.
Industry Context
Schedule 13G filings are routine disclosures by institutional investors who acquire more than 5% of a company's voting securities, or whose ownership changes relative to that threshold. They provide transparency into significant institutional holdings and shifts, which can influence market perception of a stock. This filing indicates a change in the reporting status of a major institutional holder.
Stakeholder Impact
- Shareholders: Provides transparency on institutional ownership changes, potentially influencing investor sentiment regarding institutional confidence in Axogen, Inc.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement, reflecting the beneficial ownership status. |
| 02/03/2025 | Filing date of the Schedule 13G Amendment No. 1 by Morgan Stanley and Morgan Stanley Capital Services LLC. |
Keywords
Axogen Inc., Morgan Stanley, Morgan Stanley Capital Services LLC, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Ownership, AXGN
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.